Hematopoietic stem cell mobilization with agents other than G-CSF

Jonathan Hoggatt, Louis M. Pelus

Research output: Chapter in Book/Report/Conference proceedingChapter

13 Citations (Scopus)

Abstract

Hematopoietic stem and progenitor mobilization has revolutionized the field of hematopoietic transplantation. Currently, hematopoietic grafts acquired from the peripheral blood of patients or donors treated with granulocyte-colony stimulating factor (G-CSF) are the preferred source for transplantation. G-CSF mobilization regimens, however, are associated with known morbidities and a significant number of normal donors and patient populations fail to mobilize sufficient numbers of hematopoietic stem and progenitor cells for transplantation, necessitating the need for non-G-CSF mobilization strategies. Mechanistic studies evaluating hematopoietic bone marrow niche interactions have uncovered novel agents with the capacity for hematopoietic mobilization. This chapter provides a comprehensive overview of mobilizing agents, other than G-CSF, and experimental procedures and technical aspects important to evaluate and define their hematopoietic mobilizing activities alone and in combination.

Original languageEnglish (US)
Title of host publicationStem Cell Mobilization
Subtitle of host publicationMethods and Protocols
PublisherHumana Press Inc.
Pages49-67
Number of pages19
ISBN (Print)9781617799426
DOIs
StatePublished - Jan 1 2012

Publication series

NameMethods in Molecular Biology
Volume904
ISSN (Print)1064-3745

Fingerprint

Hematopoietic Stem Cell Mobilization
Granulocyte Colony-Stimulating Factor
Transplantation
Tissue Donors
Colony-Stimulating Factors
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells
Bone Marrow
Morbidity
Transplants
Population

Keywords

  • AMD3100
  • BIO5192
  • CXCR4
  • Fucoidan
  • G-CSF
  • GRO beta
  • Hematopoietic stem cells
  • Mobilization
  • SDF-1
  • VLA-4 inhibitor

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Hoggatt, J., & Pelus, L. M. (2012). Hematopoietic stem cell mobilization with agents other than G-CSF. In Stem Cell Mobilization: Methods and Protocols (pp. 49-67). (Methods in Molecular Biology; Vol. 904). Humana Press Inc.. https://doi.org/10.1007/978-1-61779-943-3_4

Hematopoietic stem cell mobilization with agents other than G-CSF. / Hoggatt, Jonathan; Pelus, Louis M.

Stem Cell Mobilization: Methods and Protocols. Humana Press Inc., 2012. p. 49-67 (Methods in Molecular Biology; Vol. 904).

Research output: Chapter in Book/Report/Conference proceedingChapter

Hoggatt, J & Pelus, LM 2012, Hematopoietic stem cell mobilization with agents other than G-CSF. in Stem Cell Mobilization: Methods and Protocols. Methods in Molecular Biology, vol. 904, Humana Press Inc., pp. 49-67. https://doi.org/10.1007/978-1-61779-943-3_4
Hoggatt J, Pelus LM. Hematopoietic stem cell mobilization with agents other than G-CSF. In Stem Cell Mobilization: Methods and Protocols. Humana Press Inc. 2012. p. 49-67. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-61779-943-3_4
Hoggatt, Jonathan ; Pelus, Louis M. / Hematopoietic stem cell mobilization with agents other than G-CSF. Stem Cell Mobilization: Methods and Protocols. Humana Press Inc., 2012. pp. 49-67 (Methods in Molecular Biology).
@inbook{c11daea3f4e845f4903f7a1241ade113,
title = "Hematopoietic stem cell mobilization with agents other than G-CSF",
abstract = "Hematopoietic stem and progenitor mobilization has revolutionized the field of hematopoietic transplantation. Currently, hematopoietic grafts acquired from the peripheral blood of patients or donors treated with granulocyte-colony stimulating factor (G-CSF) are the preferred source for transplantation. G-CSF mobilization regimens, however, are associated with known morbidities and a significant number of normal donors and patient populations fail to mobilize sufficient numbers of hematopoietic stem and progenitor cells for transplantation, necessitating the need for non-G-CSF mobilization strategies. Mechanistic studies evaluating hematopoietic bone marrow niche interactions have uncovered novel agents with the capacity for hematopoietic mobilization. This chapter provides a comprehensive overview of mobilizing agents, other than G-CSF, and experimental procedures and technical aspects important to evaluate and define their hematopoietic mobilizing activities alone and in combination.",
keywords = "AMD3100, BIO5192, CXCR4, Fucoidan, G-CSF, GRO beta, Hematopoietic stem cells, Mobilization, SDF-1, VLA-4 inhibitor",
author = "Jonathan Hoggatt and Pelus, {Louis M.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-1-61779-943-3_4",
language = "English (US)",
isbn = "9781617799426",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "49--67",
booktitle = "Stem Cell Mobilization",

}

TY - CHAP

T1 - Hematopoietic stem cell mobilization with agents other than G-CSF

AU - Hoggatt, Jonathan

AU - Pelus, Louis M.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Hematopoietic stem and progenitor mobilization has revolutionized the field of hematopoietic transplantation. Currently, hematopoietic grafts acquired from the peripheral blood of patients or donors treated with granulocyte-colony stimulating factor (G-CSF) are the preferred source for transplantation. G-CSF mobilization regimens, however, are associated with known morbidities and a significant number of normal donors and patient populations fail to mobilize sufficient numbers of hematopoietic stem and progenitor cells for transplantation, necessitating the need for non-G-CSF mobilization strategies. Mechanistic studies evaluating hematopoietic bone marrow niche interactions have uncovered novel agents with the capacity for hematopoietic mobilization. This chapter provides a comprehensive overview of mobilizing agents, other than G-CSF, and experimental procedures and technical aspects important to evaluate and define their hematopoietic mobilizing activities alone and in combination.

AB - Hematopoietic stem and progenitor mobilization has revolutionized the field of hematopoietic transplantation. Currently, hematopoietic grafts acquired from the peripheral blood of patients or donors treated with granulocyte-colony stimulating factor (G-CSF) are the preferred source for transplantation. G-CSF mobilization regimens, however, are associated with known morbidities and a significant number of normal donors and patient populations fail to mobilize sufficient numbers of hematopoietic stem and progenitor cells for transplantation, necessitating the need for non-G-CSF mobilization strategies. Mechanistic studies evaluating hematopoietic bone marrow niche interactions have uncovered novel agents with the capacity for hematopoietic mobilization. This chapter provides a comprehensive overview of mobilizing agents, other than G-CSF, and experimental procedures and technical aspects important to evaluate and define their hematopoietic mobilizing activities alone and in combination.

KW - AMD3100

KW - BIO5192

KW - CXCR4

KW - Fucoidan

KW - G-CSF

KW - GRO beta

KW - Hematopoietic stem cells

KW - Mobilization

KW - SDF-1

KW - VLA-4 inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84934443733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934443733&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-943-3_4

DO - 10.1007/978-1-61779-943-3_4

M3 - Chapter

C2 - 22890921

AN - SCOPUS:84934443733

SN - 9781617799426

T3 - Methods in Molecular Biology

SP - 49

EP - 67

BT - Stem Cell Mobilization

PB - Humana Press Inc.

ER -